The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including high-cost medications like Botox and Trulicity. This third cycle of negotiations is the first to include drugs payable under Medicare Part B, which are traditionally administered in clinical settings, in addition… Â
